BEAM vs WDAY · rev $32.2M vs P/E 135, rev $5.19B
Beam Therapeutics Inc (BEAM) versus Workday Inc (WDAY) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Workday Inc (WDAY) is a software - application company listed on US.
Latest reported BEAM revenue for 2026-06-30 was $32.2M. Net income was -$217.0M. Revenue was up 1.5% from 2026-03-31 to 2026-06-30. BEAM currently screens at market cap $2.01B.
Latest reported WDAY revenue for 2026-07-31 was $5.19B. Net income was $854.0M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
BEAM currently screens at market cap $2.01B. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
Not investment advice. Open the BEAM and WDAY stock pages for the full models.
Not investment advice.